26-A-15687-ACC SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS (SGLT2I) POST-TRANS CATHETER AORTIC VALVE IMPLANTATION (TAVI): REAL-WORLD SURVIVAL BENEFITS ACROSS THE HEART FAILURE (HF) SPECTRUM
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Cardiac Valve Diseases and Treatments
Aortic Disease and Treatment Approaches
Heart Failure Treatment and Management
Publication details
- Journal / source
- Journal of the American College of Cardiology
- Volume
- 87
- Issue
- 13
- Pages
- A495–A496
- Publication date
- 27 March 2026
- Language
- EN